Clinical Trial Update: Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors [Phase 4]

View source ↗

Summary

Update on a Phase 4 trial assessing the diagnostic usefulness of serum chromogranin A for pancreatic neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Snippet

Sponsor: Asan Medical Center | Conditions: Non Functioning Pancreatic Endocrine Tumor | Phase 4 | Status: UNKNOWN